NCT07639086
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07639086
Title Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy (STOP-NEPC)
Acronym STOP-NEPC
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field